Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens

被引:130
作者
Iwasaki, Masashi [3 ]
Tanaka, Yoshimasa [1 ,2 ]
Kobayashi, Hirohito [4 ]
Murata-Hirai, Kaoru
Miyabe, Hideto
Sugie, Tomoharu [5 ]
Toi, Masakazu [5 ]
Minato, Nagahiro [1 ,3 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Biostudies, Lab Immunol & Cell Biol, Kyoto, Japan
[4] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[5] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan
关键词
gamma delta T cells; Phosphoantigen; PD-1; PD-L1; Tumor; NONPEPTIDE ANTIGENS; DILATED CARDIOMYOPATHY; MEDIATED RECOGNITION; ZOLEDRONIC ACID; TUMOR-CELLS; IN-VIVO; IMMUNOTHERAPY; RECEPTOR; B7-H1; PATHWAY;
D O I
10.1002/eji.201040959
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Programmed cell death-1 (PD-1) is an inhibitory receptor and plays an important role in the regulation of alpha beta T cells. Little is known, however, about the role of PD-1 in gamma delta T cells. In this study, we investigated the expression and function of PD-1 in human gamma delta T cells. Expression of PD-1 was rapidly induced in primary gamma delta T cells following antigenic stimulation, and the PD-1(+) gamma delta T cells produced IL-2. When PD-1(+) gamma delta T cells were stimulated with Daudi cells with and without programmed cell death ligand-1 (PD-L1) expression, the levels of IFN-gamma production and cytotoxicity in response to PD-L1(+) Daudi cells were diminished compared to the levels seen in response to PD-L1(-) Daudi cells. The attenuated effector functions were reversed by anti-PD-L1 mAb. When PD-L1(+) gamma delta T cells were challenged by PD-L1(+) tumors pretreated with zoledronate (Zol), which induced gamma delta TCR-mediated signaling, the resulting reduction in cytokine production was only slight to moderate compared to the reduction seen when PD-L1(+) gamma delta T cells were challenged by PD-L1(-) tumors. In addition, cytotoxic activity of PD-L1(+) gamma delta T cells against Zol-treated PD-L1(+) tumors was comparable to that against Zol-treated PD-L1(-) tumors. These results suggest that TCR triggering may partially overcome the inhibitory effect of PD-1 in gamma delta T cells.
引用
收藏
页码:345 / 355
页数:11
相关论文
共 50 条
  • [11] Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
    Dieli, Francesco
    Vermijlen, David
    Fulfaro, Fabio
    Caccamo, Nadia
    Meraviglia, Serena
    Cicero, Giuseppe
    Roberts, Andrew
    Buccheri, Simona
    D'Asaro, Matilde
    Gebbia, Nicola
    Salerno, Alfredo
    Eberl, Matthias
    Hayday, Adrian C.
    [J]. CANCER RESEARCH, 2007, 67 (15) : 7450 - 7457
  • [12] B7-H1 pathway and its role in the evasion of tumor immunity
    Dong, HD
    Chen, LP
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (05): : 281 - 287
  • [13] Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235
  • [14] Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
    Freeman, GJ
    Long, AJ
    Iwai, Y
    Bourque, K
    Chernova, T
    Nishimura, H
    Fitz, LJ
    Malenkovich, N
    Okazaki, T
    Byrne, MC
    Horton, HF
    Fouser, L
    Carter, L
    Ling, V
    Bowman, MR
    Carreno, BM
    Collins, M
    Wood, CR
    Honjo, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) : 1027 - 1034
  • [15] Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade
    Freeman, Gordon J.
    Wherry, E. John
    Ahmed, Rafi
    Sharpe, Arlene H.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (10) : 2223 - 2227
  • [16] Garcia VE, 1997, J IMMUNOL, V159, P1328
  • [17] Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
    Gnant, Michael
    Mlineritsch, Brigitte
    Schippinger, Walter
    Luschin-Ebengreuth, Gero
    Poestlberger, Sabine
    Menzel, Christian
    Jakesz, Raimund
    Seifert, Michael
    Hubalek, Michael
    Bjelic-Radisic, Vesna
    Samonigg, Hellmut
    Tausch, Christoph
    Eidtmann, Holger
    Steger, Guenther
    Kwasny, Werner
    Dubsky, Peter
    Fridrik, Michael
    Fitzal, Florian
    Stierer, Michael
    Rucklinger, Ernst
    Greil, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (07) : 679 - 691
  • [18] Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
    Gober, HJ
    Kistowska, M
    Angman, L
    Jenö, P
    Mori, L
    De Libero, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) : 163 - 168
  • [19] Greenwald RJ., 2005, Annu Rev Immunol, V23, P515548
  • [20] Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
    Hamanishi, Junzo
    Mandai, Masaki
    Iwasaki, Masashi
    Okazaki, Taku
    Tanaka, Yoshimasa
    Yamaguchi, Ken
    Higuchi, Toshihiro
    Yagi, Haruhiko
    Takakura, Kenji
    Minato, Nagahiro
    Honjo, Tasuku
    Fujii, Shingo
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (09) : 3360 - 3365